Antares Pharma Inc (NASDAQ:ATRS)

2.06
Delayed Data
As of Jul 28
 +0.06 / +3.00%
Today’s Change
1.82
Today|||52-Week Range
3.04
-19.84%
Year-to-Date

Stock Price Forecast

The 4 analysts offering 12-month price forecasts for Antares Pharma Inc have a median target of 4.50, with a high estimate of 5.00 and a low estimate of 3.50. The median estimate represents a +118.45% increase from the last price of 2.06.

Analyst Recommendations

The current consensus among 4 polled investment analysts is to Buy stock in Antares Pharma Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.03
Sales
$11.0M
Reporting Date
Aug 05

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 40.00%
 
 
 
 
 
 
Growthannually 66.67%
 
 
 
 
 
 

Sales

Growthquarterly 32.26%
 
 
 
 
 
 
Growthannually 73.82%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account